Kane William 4
4 · Citius Pharmaceuticals, Inc. · Filed Sep 6, 2018
Insider Transaction Report
Form 4
Kane William
Director
Transactions
- Award
Options to Purchase Common Stock
2018-09-04+15,000→ 15,000 totalExercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying)
Holdings
- 13,334
Options to Purchase Common Stock
Exercise: $12.00Exp: 2026-06-23→ Common Stock (13,334 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying) - 12,071
Options to Purchase Common Stock
Exercise: $0.01Exp: 2024-03-28→ Common Stock (12,071 underlying)
Footnotes (4)
- [F1]The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.
- [F2]The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018.
- [F3]The option vested in 1/3 increments over a three year period with the first installment vesting on March 28, 2015.
- [F4]The options vested in full on the first anniversary of the date of grant.